Optimizing the Timing and Sequencing of Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer

Decera Clinical Education Oncology Podcast · Apr 28, 2021 · 15m

In this episode, Joleen Hubbard, MD, and John L. Marshall, MD, discuss use of the later-line treatment options regorafenib and TAS-102 for patients with mCRC, with topics including:

Key data supporting the clinical use of these agents

Optimal sequencing and timing of use

Dosing considerations

Key adverse events

Presenters:

Joleen Hubbard, MD

Associate Professor

Gastrointestinal Oncologist

Medical Oncology

Mayo Clinic

Rochester, Minnesota

John L. Marshall, MD

Chief, Division of Hematology/Oncology

Department of Medicine

Georgetown University Hospital

Washington, DC

Content based on an online…